Ifp Advisors, Inc Adverum Biotechnologies, Inc. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.81 - $1.34 $4,860 - $8,040	6,000 New	6,000 $38,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.34 $4,860 - $8,040	-6,000 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$1.23 - $1.95 $7,380 - $11,700	6,000 New	6,000 $7,000
Q3 2021 Oct 06, 2021	SELL	$2.08 - $3.6 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$3.36 - $10.56 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$9.26 - $14.36 $194 - $301	-21 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$9.84 - $14.26 $127 - $185	-13 Reduced 38.24%	21 $0
Q3 2020 Oct 29, 2020	BUY	$10.3 - $21.64 $350 - $735	34 New	34 $0
Q3 2019 Nov 07, 2019	SELL	$5.24 - $15.89 $31,440 - $95,340	-6,000 Closed	0 $0
Q1 2016 Jun 03, 2019	BUY	N/A	6,000	6,000 $31,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.